Rank | Gene Set | Z-score |
---|---|---|
1 | neutrophil activation involved in immune response (GO:0002283) | 5.74380322 |
2 | aldehyde catabolic process (GO:0046185) | 5.63335517 |
3 | establishment of integrated proviral latency (GO:0075713) | 5.38481613 |
4 | hydrogen peroxide biosynthetic process (GO:0050665) | 5.08413080 |
5 | ribosome assembly (GO:0042255) | 4.73527946 |
6 | respiratory burst (GO:0045730) | 4.57716211 |
7 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 4.51786184 |
8 | positive regulation of interferon-alpha production (GO:0032727) | 4.49743674 |
9 | reactive oxygen species biosynthetic process (GO:1903409) | 4.45029395 |
10 | superoxide anion generation (GO:0042554) | 4.43801698 |
11 | establishment of viral latency (GO:0019043) | 4.29314949 |
12 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.27429105 |
13 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 4.27223749 |
14 | negative regulation of ligase activity (GO:0051352) | 4.22059264 |
15 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 4.22059264 |
16 | regulation of interferon-alpha production (GO:0032647) | 4.20746960 |
17 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 4.15322527 |
18 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 4.13570583 |
19 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.93385087 |
20 | response to peptidoglycan (GO:0032494) | 3.93316143 |
21 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.93096573 |
22 | formation of translation preinitiation complex (GO:0001731) | 3.92203994 |
23 | mitotic metaphase plate congression (GO:0007080) | 3.91087783 |
24 | granulocyte activation (GO:0036230) | 3.88722481 |
25 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.87508850 |
26 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.87271887 |
27 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.78850645 |
28 | DNA strand elongation (GO:0022616) | 3.77884674 |
29 | CENP-A containing nucleosome assembly (GO:0034080) | 3.76862480 |
30 | eosinophil chemotaxis (GO:0048245) | 3.74350910 |
31 | purine nucleobase biosynthetic process (GO:0009113) | 3.72587188 |
32 | immunoglobulin mediated immune response (GO:0016064) | 3.71876942 |
33 | chromatin remodeling at centromere (GO:0031055) | 3.69717814 |
34 | chaperone-mediated protein transport (GO:0072321) | 3.69448948 |
35 | ribosomal large subunit biogenesis (GO:0042273) | 3.64255004 |
36 | IMP biosynthetic process (GO:0006188) | 3.63546283 |
37 | regulation of mitochondrial translation (GO:0070129) | 3.61872732 |
38 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.60653135 |
39 | neutrophil activation (GO:0042119) | 3.56908549 |
40 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.56600285 |
41 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.56600285 |
42 | modulation by symbiont of host immune response (GO:0052553) | 3.56600285 |
43 | positive regulation by symbiont of host defense response (GO:0052509) | 3.56600285 |
44 | modulation by symbiont of host defense response (GO:0052031) | 3.56600285 |
45 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.56600285 |
46 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.56504877 |
47 | regulation of activation of Janus kinase activity (GO:0010533) | 3.56174424 |
48 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.54980879 |
49 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.54980879 |
50 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.54980879 |
51 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.54978170 |
52 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.54566375 |
53 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.54566375 |
54 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.53059701 |
55 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.49804781 |
56 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.49804781 |
57 | protein complex localization (GO:0031503) | 3.48400136 |
58 | nucleobase biosynthetic process (GO:0046112) | 3.47610882 |
59 | protein localization to kinetochore (GO:0034501) | 3.44893138 |
60 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.44763099 |
61 | regulation of mononuclear cell migration (GO:0071675) | 3.44582505 |
62 | positive regulation of ligase activity (GO:0051351) | 3.44042731 |
63 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.41913549 |
64 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 3.40761253 |
65 | DNA replication checkpoint (GO:0000076) | 3.39268633 |
66 | ATP synthesis coupled proton transport (GO:0015986) | 3.38696709 |
67 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.38696709 |
68 | rRNA modification (GO:0000154) | 3.37247716 |
69 | L-serine metabolic process (GO:0006563) | 3.35826120 |
70 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.34302177 |
71 | cellular response to interferon-alpha (GO:0035457) | 3.31829014 |
72 | spliceosomal snRNP assembly (GO:0000387) | 3.31635176 |
73 | regulation of ligase activity (GO:0051340) | 3.30898290 |
74 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 3.30675280 |
75 | metaphase plate congression (GO:0051310) | 3.28818238 |
76 | ribosomal small subunit assembly (GO:0000028) | 3.27685097 |
77 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.27499612 |
78 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.27215054 |
79 | eosinophil migration (GO:0072677) | 3.26933032 |
80 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.25131607 |
81 | IMP metabolic process (GO:0046040) | 3.22956778 |
82 | protein targeting to mitochondrion (GO:0006626) | 3.21287409 |
83 | maturation of SSU-rRNA (GO:0030490) | 3.21150734 |
84 | B cell mediated immunity (GO:0019724) | 3.20592753 |
85 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.18357040 |
86 | termination of RNA polymerase III transcription (GO:0006386) | 3.18357040 |
87 | DNA unwinding involved in DNA replication (GO:0006268) | 3.18128129 |
88 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.16574168 |
89 | protein localization to chromosome, centromeric region (GO:0071459) | 3.16137865 |
90 | cellular protein complex localization (GO:0034629) | 3.16130732 |
91 | monocyte chemotaxis (GO:0002548) | 3.15771014 |
92 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.15445331 |
93 | tRNA aminoacylation for protein translation (GO:0006418) | 3.13977084 |
94 | cellular response to interferon-beta (GO:0035458) | 3.11429541 |
95 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 3.11096622 |
96 | mitotic sister chromatid segregation (GO:0000070) | 3.10235992 |
97 | cell cycle G1/S phase transition (GO:0044843) | 3.10000565 |
98 | G1/S transition of mitotic cell cycle (GO:0000082) | 3.10000565 |
99 | ribosome biogenesis (GO:0042254) | 3.09812427 |
100 | amino acid activation (GO:0043038) | 3.08122454 |
101 | tRNA aminoacylation (GO:0043039) | 3.08122454 |
102 | histone exchange (GO:0043486) | 3.05261215 |
103 | ribosomal small subunit biogenesis (GO:0042274) | 3.04145018 |
104 | response to interferon-beta (GO:0035456) | 3.03719095 |
105 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.03399499 |
106 | pseudouridine synthesis (GO:0001522) | 3.03383986 |
107 | L-ascorbic acid metabolic process (GO:0019852) | 3.02939954 |
108 | regulation of chemokine biosynthetic process (GO:0045073) | 3.02436762 |
109 | telomere maintenance via recombination (GO:0000722) | 3.02302594 |
110 | T-helper 1 type immune response (GO:0042088) | 3.01986159 |
111 | rRNA processing (GO:0006364) | 3.00904385 |
112 | positive regulation of interferon-beta production (GO:0032728) | 3.00476141 |
113 | oxidative phosphorylation (GO:0006119) | 3.00009790 |
114 | DNA replication-independent nucleosome assembly (GO:0006336) | 2.99508099 |
115 | DNA replication-independent nucleosome organization (GO:0034724) | 2.99508099 |
116 | translation (GO:0006412) | 2.99328703 |
117 | nuclear pore complex assembly (GO:0051292) | 2.98189004 |
118 | low-density lipoprotein particle clearance (GO:0034383) | 2.97817120 |
119 | regulation of translational fidelity (GO:0006450) | 2.97328095 |
120 | mitochondrial RNA metabolic process (GO:0000959) | 2.97229650 |
121 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.97212567 |
122 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.94311968 |
123 | establishment of protein localization to mitochondrion (GO:0072655) | 2.94073249 |
124 | protein localization to mitochondrion (GO:0070585) | 2.93853107 |
125 | tricarboxylic acid cycle (GO:0006099) | 2.93803742 |
126 | negative regulation of protein ubiquitination (GO:0031397) | 2.93256389 |
127 | mitotic recombination (GO:0006312) | 2.93203035 |
128 | positive regulation of type 2 immune response (GO:0002830) | 2.92384458 |
129 | mitotic nuclear envelope disassembly (GO:0007077) | 2.92037707 |
130 | negative regulation of viral genome replication (GO:0045071) | 2.90847324 |
131 | non-recombinational repair (GO:0000726) | 2.90507113 |
132 | double-strand break repair via nonhomologous end joining (GO:0006303) | 2.90507113 |
133 | type I interferon signaling pathway (GO:0060337) | 2.90069760 |
134 | cellular response to type I interferon (GO:0071357) | 2.90069760 |
135 | regulation of cellular amine metabolic process (GO:0033238) | 2.90043796 |
136 | maturation of 5.8S rRNA (GO:0000460) | 2.89186820 |
137 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.88361331 |
138 | protein maturation by protein folding (GO:0022417) | 2.88260306 |
139 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.85817444 |
140 | regulation of fever generation (GO:0031620) | 2.85383835 |
141 | response to type I interferon (GO:0034340) | 2.84983982 |
142 | wound healing, spreading of epidermal cells (GO:0035313) | 2.84843979 |
143 | rRNA metabolic process (GO:0016072) | 2.84732466 |
144 | spindle checkpoint (GO:0031577) | 2.84396381 |
145 | positive regulation of heat generation (GO:0031652) | 2.84386290 |
146 | negative regulation of chromosome segregation (GO:0051985) | 2.83499392 |
147 | negative regulation of mitotic sister chromatid separation (GO:2000816) | 2.83393029 |
148 | negative regulation of sister chromatid segregation (GO:0033046) | 2.83393029 |
149 | negative regulation of mitotic metaphase/anaphase transition (GO:0045841) | 2.83393029 |
150 | negative regulation of metaphase/anaphase transition of cell cycle (GO:1902100) | 2.83393029 |
151 | negative regulation of mitotic sister chromatid segregation (GO:0033048) | 2.83393029 |
152 | phagosome maturation (GO:0090382) | 2.81566912 |
153 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.80151868 |
154 | cellular response to exogenous dsRNA (GO:0071360) | 2.79832614 |
155 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.79773833 |
156 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.77585671 |
157 | defense response to protozoan (GO:0042832) | 2.77494737 |
158 | response to interferon-alpha (GO:0035455) | 2.77028485 |
159 | protein neddylation (GO:0045116) | 2.75562782 |
160 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.73473037 |
161 | positive regulation of cAMP-mediated signaling (GO:0043950) | 2.73356824 |
162 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 2.73151861 |
163 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.72386090 |
164 | lymphocyte chemotaxis (GO:0048247) | 2.67734638 |
165 | positive regulation of lymphocyte migration (GO:2000403) | 2.66946297 |
166 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 2.66743876 |
167 | proteasome assembly (GO:0043248) | 2.66036076 |
168 | cellular response to zinc ion (GO:0071294) | 2.65962098 |
169 | myeloid cell activation involved in immune response (GO:0002275) | 2.60359833 |
170 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.59130755 |
171 | negative regulation by host of viral transcription (GO:0043922) | 2.58934845 |
172 | phagocytosis, recognition (GO:0006910) | 2.58438385 |
173 | macrophage activation involved in immune response (GO:0002281) | 2.57955980 |
174 | macrophage chemotaxis (GO:0048246) | 2.56572920 |
175 | positive regulation of interleukin-12 production (GO:0032735) | 2.55166530 |
176 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.54629466 |
177 | uronic acid metabolic process (GO:0006063) | 2.52394356 |
178 | glucuronate metabolic process (GO:0019585) | 2.52394356 |
179 | cellular response to virus (GO:0098586) | 2.51133591 |
180 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.50961131 |
181 | regulation of immunoglobulin secretion (GO:0051023) | 2.50623917 |
182 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.50311071 |
183 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.48632250 |
184 | positive regulation of interleukin-17 production (GO:0032740) | 2.48272039 |
185 | response to muramyl dipeptide (GO:0032495) | 2.46669140 |
186 | regulation of RIG-I signaling pathway (GO:0039535) | 2.46618988 |
187 | regulation of metalloenzyme activity (GO:0048552) | 2.45726940 |
188 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.45673561 |
189 | positive regulation of antigen processing and presentation (GO:0002579) | 2.43647091 |
190 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 2.43524977 |
191 | positive regulation of actin filament depolymerization (GO:0030836) | 2.42522230 |
192 | regulation of monocyte chemotaxis (GO:0090025) | 2.41723922 |
193 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.41575636 |
194 | positive regulation of mast cell degranulation (GO:0043306) | 2.41575636 |
195 | positive regulation of chemokine production (GO:0032722) | 2.41402192 |
196 | positive regulation of interleukin-6 production (GO:0032755) | 2.41296840 |
197 | * superoxide metabolic process (GO:0006801) | 2.40963786 |
198 | positive regulation of response to biotic stimulus (GO:0002833) | 2.39677941 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.96056247 |
2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.81515667 |
3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.42221573 |
4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.44722804 |
5 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 3.29096007 |
6 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.11897155 |
7 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.06450641 |
8 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.01757662 |
9 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.86338039 |
10 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.82878285 |
11 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.71249878 |
12 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.65897945 |
13 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.59685016 |
14 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.53274741 |
15 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.45403693 |
16 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.42833254 |
17 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.42704364 |
18 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.37318084 |
19 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.36884951 |
20 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.32972502 |
21 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.31123199 |
22 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.30664524 |
23 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.23546705 |
24 | * XRN2_22483619_ChIP-Seq_HELA_Human | 2.20658617 |
25 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.12271712 |
26 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 2.02217354 |
27 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.00656019 |
28 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.97489171 |
29 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.95926364 |
30 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.94315912 |
31 | * TTF2_22483619_ChIP-Seq_HELA_Human | 1.91170040 |
32 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.89399610 |
33 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.87523351 |
34 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.85753155 |
35 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.84797350 |
36 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.84000202 |
37 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.83375329 |
38 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.80076149 |
39 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.77432204 |
40 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.76434073 |
41 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.74685217 |
42 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.73893787 |
43 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.72378733 |
44 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.69873055 |
45 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.67606045 |
46 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.67188794 |
47 | * MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.66593626 |
48 | * CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.64390131 |
49 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.61144396 |
50 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.61095739 |
51 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.60768998 |
52 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.59648640 |
53 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.57182894 |
54 | * MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.55311529 |
55 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.51441669 |
56 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.49433779 |
57 | * PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.49343231 |
58 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.44748555 |
59 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.44321608 |
60 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.39162127 |
61 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.38948260 |
62 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.38623541 |
63 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.38507933 |
64 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.38491128 |
65 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.36442232 |
66 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.36085579 |
67 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.35344289 |
68 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.33838526 |
69 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.30493371 |
70 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.30408091 |
71 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.29489746 |
72 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.28750364 |
73 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.26907055 |
74 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.26851061 |
75 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.26204418 |
76 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.23771032 |
77 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.21853931 |
78 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.21853931 |
79 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.21582976 |
80 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.20785730 |
81 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.20785730 |
82 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.20785730 |
83 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.19403705 |
84 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.19230201 |
85 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.19169775 |
86 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.19079173 |
87 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.16927933 |
88 | * DCP1A_22483619_ChIP-Seq_HELA_Human | 1.16266026 |
89 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.14876829 |
90 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.14438734 |
91 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.14238269 |
92 | * E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.13717623 |
93 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.13714807 |
94 | * HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.11187502 |
95 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.10344656 |
96 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.08892375 |
97 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.08840060 |
98 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.08622839 |
99 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.08251989 |
100 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.08194228 |
101 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.06468820 |
102 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06109273 |
103 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.06017462 |
104 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 1.05663626 |
105 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.05470714 |
106 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.05207246 |
107 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05043898 |
108 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 1.04652930 |
109 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.04391569 |
110 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.03285734 |
111 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.03035101 |
112 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.02799030 |
113 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.02771325 |
114 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.02589951 |
115 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.02290628 |
116 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.02018076 |
117 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.01576876 |
118 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.01492999 |
119 | * NANOG_18692474_ChIP-Seq_MEFs_Mouse | 1.00661941 |
120 | * SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.99885122 |
121 | * CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.99850377 |
122 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.99500604 |
123 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.99252130 |
124 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.98389220 |
125 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.96928481 |
126 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.96160374 |
127 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.96019523 |
128 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.95288433 |
129 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 0.94716496 |
130 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.94484756 |
131 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.93618487 |
132 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.93473834 |
133 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.93002572 |
134 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.92210433 |
135 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.91633501 |
136 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.91413157 |
137 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.90830331 |
138 | * CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.90761747 |
139 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.90371553 |
140 | * KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.90009296 |
141 | * OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.89920834 |
142 | * STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.89792064 |
143 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.89277104 |
144 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.88298086 |
145 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.87962162 |
146 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.87905396 |
147 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.87639311 |
148 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.87238312 |
149 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.86730892 |
150 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.86538708 |
151 | GATA3_26560356_Chip-Seq_TH2_Human | 0.86347466 |
152 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.85518324 |
153 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.85113168 |
154 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.84526568 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0004957_abnormal_blastocyst_morpholog | 4.80739777 |
2 | MP0010094_abnormal_chromosome_stability | 3.98765976 |
3 | MP0003111_abnormal_nucleus_morphology | 3.80328465 |
4 | MP0003806_abnormal_nucleotide_metabolis | 3.67287985 |
5 | MP0001835_abnormal_antigen_presentation | 3.60955897 |
6 | MP0006082_CNS_inflammation | 3.58817356 |
7 | MP0009785_altered_susceptibility_to | 3.57121447 |
8 | MP0002148_abnormal_hypersensitivity_rea | 3.43742727 |
9 | MP0008058_abnormal_DNA_repair | 3.41965901 |
10 | * MP0003077_abnormal_cell_cycle | 3.20408256 |
11 | MP0003436_decreased_susceptibility_to | 3.17868072 |
12 | MP0008932_abnormal_embryonic_tissue | 3.13147744 |
13 | * MP0003186_abnormal_redox_activity | 3.04593371 |
14 | MP0003724_increased_susceptibility_to | 2.85626956 |
15 | MP0002419_abnormal_innate_immunity | 2.75579468 |
16 | MP0008007_abnormal_cellular_replicative | 2.70461634 |
17 | MP0005000_abnormal_immune_tolerance | 2.66121266 |
18 | MP0005025_abnormal_response_to | 2.60542992 |
19 | MP0005058_abnormal_lysosome_morphology | 2.56517570 |
20 | MP0003195_calcinosis | 2.52130730 |
21 | MP0001730_embryonic_growth_arrest | 2.33119339 |
22 | MP0001853_heart_inflammation | 2.24543458 |
23 | MP0003303_peritoneal_inflammation | 2.22706927 |
24 | MP0003890_abnormal_embryonic-extraembry | 2.13720976 |
25 | MP0009697_abnormal_copulation | 2.11862060 |
26 | MP0002452_abnormal_antigen_presenting | 2.01520877 |
27 | MP0003136_yellow_coat_color | 1.99059096 |
28 | MP0005387_immune_system_phenotype | 1.94710455 |
29 | MP0001790_abnormal_immune_system | 1.94710455 |
30 | MP0005671_abnormal_response_to | 1.92154616 |
31 | MP0009764_decreased_sensitivity_to | 1.90953590 |
32 | MP0010030_abnormal_orbit_morphology | 1.89336765 |
33 | MP0002723_abnormal_immune_serum | 1.88208157 |
34 | * MP0000350_abnormal_cell_proliferation | 1.82978775 |
35 | MP0003786_premature_aging | 1.77621879 |
36 | MP0006035_abnormal_mitochondrial_morpho | 1.73494320 |
37 | MP0001533_abnormal_skeleton_physiology | 1.73448933 |
38 | MP0001672_abnormal_embryogenesis/_devel | 1.70288524 |
39 | MP0005380_embryogenesis_phenotype | 1.70288524 |
40 | MP0005408_hypopigmentation | 1.65234669 |
41 | MP0002796_impaired_skin_barrier | 1.65214841 |
42 | MP0000343_altered_response_to | 1.64185696 |
43 | MP0001697_abnormal_embryo_size | 1.63696401 |
44 | * MP0003448_altered_tumor_morphology | 1.62750190 |
45 | MP0003950_abnormal_plasma_membrane | 1.62683885 |
46 | MP0008469_abnormal_protein_level | 1.61991398 |
47 | MP0001800_abnormal_humoral_immune | 1.61850599 |
48 | MP0006036_abnormal_mitochondrial_physio | 1.61698532 |
49 | MP0000685_abnormal_immune_system | 1.59608759 |
50 | MP0003690_abnormal_glial_cell | 1.58187521 |
51 | MP0001845_abnormal_inflammatory_respons | 1.58165846 |
52 | MP0002080_prenatal_lethality | 1.57188901 |
53 | MP0004510_myositis | 1.53599806 |
54 | * MP0001819_abnormal_immune_cell | 1.50950275 |
55 | MP0000358_abnormal_cell_content/ | 1.50892086 |
56 | MP0005501_abnormal_skin_physiology | 1.47511397 |
57 | MP0005164_abnormal_response_to | 1.46307213 |
58 | MP0002277_abnormal_respiratory_mucosa | 1.46064659 |
59 | MP0009840_abnormal_foam_cell | 1.45815631 |
60 | * MP0002420_abnormal_adaptive_immunity | 1.45756750 |
61 | MP0004947_skin_inflammation | 1.45187930 |
62 | MP0002085_abnormal_embryonic_tissue | 1.44021742 |
63 | MP0004782_abnormal_surfactant_physiolog | 1.43999383 |
64 | MP0000858_altered_metastatic_potential | 1.43523455 |
65 | MP0000920_abnormal_myelination | 1.43326805 |
66 | MP0002084_abnormal_developmental_patter | 1.43245346 |
67 | MP0002405_respiratory_system_inflammati | 1.42987885 |
68 | MP0003984_embryonic_growth_retardation | 1.42029575 |
69 | MP0009672_abnormal_birth_weight | 1.40307016 |
70 | MP0005360_urolithiasis | 1.38516798 |
71 | MP0003075_altered_response_to | 1.38013254 |
72 | MP0009379_abnormal_foot_pigmentation | 1.37951242 |
73 | MP0002088_abnormal_embryonic_growth/wei | 1.37387351 |
74 | MP0003315_abnormal_perineum_morphology | 1.36617857 |
75 | MP0001293_anophthalmia | 1.35144370 |
76 | MP0005464_abnormal_platelet_physiology | 1.32785383 |
77 | MP0000537_abnormal_urethra_morphology | 1.30972002 |
78 | MP0002877_abnormal_melanocyte_morpholog | 1.30715166 |
79 | MP0003453_abnormal_keratinocyte_physiol | 1.27753899 |
80 | * MP0000313_abnormal_cell_death | 1.27522437 |
81 | MP0010155_abnormal_intestine_physiology | 1.26828935 |
82 | MP0002998_abnormal_bone_remodeling | 1.26208073 |
83 | MP0009763_increased_sensitivity_to | 1.25171241 |
84 | MP0005451_abnormal_body_composition | 1.25167752 |
85 | MP0000490_abnormal_crypts_of | 1.24163124 |
86 | MP0009333_abnormal_splenocyte_physiolog | 1.23895281 |
87 | MP0002139_abnormal_hepatobiliary_system | 1.23767946 |
88 | MP0005166_decreased_susceptibility_to | 1.20298200 |
89 | MP0010234_abnormal_vibrissa_follicle | 1.19807196 |
90 | MP0000372_irregular_coat_pigmentation | 1.18557432 |
91 | MP0005171_absent_coat_pigmentation | 1.18530976 |
92 | MP0000604_amyloidosis | 1.18201375 |
93 | MP0002086_abnormal_extraembryonic_tissu | 1.18003281 |
94 | MP0004233_abnormal_muscle_weight | 1.16552918 |
95 | MP0010352_gastrointestinal_tract_polyps | 1.12799441 |
96 | MP0002254_reproductive_system_inflammat | 1.09645135 |
97 | MP0003191_abnormal_cellular_cholesterol | 1.09478043 |
98 | MP0008438_abnormal_cutaneous_collagen | 1.07300861 |
99 | MP0003567_abnormal_fetal_cardiomyocyte | 1.06878169 |
100 | MP0008875_abnormal_xenobiotic_pharmacok | 1.06662792 |
101 | MP0008260_abnormal_autophagy | 1.05780959 |
102 | MP0003718_maternal_effect | 1.04213504 |
103 | MP0002111_abnormal_tail_morphology | 1.04199662 |
104 | MP0002006_tumorigenesis | 1.03970445 |
105 | MP0002697_abnormal_eye_size | 1.03874950 |
106 | MP0003937_abnormal_limbs/digits/tail_de | 1.03286204 |
107 | MP0002090_abnormal_vision | 1.03159411 |
108 | MP0010307_abnormal_tumor_latency | 1.01542527 |
109 | MP0001727_abnormal_embryo_implantation | 0.99618712 |
110 | MP0004264_abnormal_extraembryonic_tissu | 0.98898812 |
111 | MP0001851_eye_inflammation | 0.97041918 |
112 | MP0002332_abnormal_exercise_endurance | 0.96815989 |
113 | MP0006292_abnormal_olfactory_placode | 0.96655919 |
114 | * MP0000716_abnormal_immune_system | 0.95842262 |
115 | MP0002138_abnormal_hepatobiliary_system | 0.93824109 |
116 | MP0002295_abnormal_pulmonary_circulatio | 0.92874578 |
117 | MP0000647_abnormal_sebaceous_gland | 0.91412725 |
118 | MP0002938_white_spotting | 0.90818248 |
119 | MP0004272_abnormal_basement_membrane | 0.90758084 |
120 | MP0005395_other_phenotype | 0.90458597 |
121 | MP0005167_abnormal_blood-brain_barrier | 0.87941170 |
122 | MP0005332_abnormal_amino_acid | 0.87694269 |
123 | MP0003172_abnormal_lysosome_physiology | 0.87642283 |
124 | MP0003941_abnormal_skin_development | 0.86956007 |
125 | MP0002136_abnormal_kidney_physiology | 0.85370623 |
126 | MP0005390_skeleton_phenotype | 0.85173318 |
127 | MP0000627_abnormal_mammary_gland | 0.83236506 |
128 | MP0000579_abnormal_nail_morphology | 0.81674743 |
129 | MP0001764_abnormal_homeostasis | 0.81474718 |
130 | MP0008004_abnormal_stomach_pH | 0.81418715 |
131 | MP0005023_abnormal_wound_healing | 0.80143515 |
132 | MP0005310_abnormal_salivary_gland | 0.79553579 |
133 | MP0005083_abnormal_biliary_tract | 0.78982458 |
134 | MP0004019_abnormal_vitamin_homeostasis | 0.78534127 |
135 | MP0005330_cardiomyopathy | 0.77708382 |
136 | MP0001881_abnormal_mammary_gland | 0.77254144 |
137 | MP0001849_ear_inflammation | 0.77252674 |
138 | * MP0002429_abnormal_blood_cell | 0.77249745 |
139 | MP0005397_hematopoietic_system_phenotyp | 0.76734532 |
140 | MP0001545_abnormal_hematopoietic_system | 0.76734532 |
141 | MP0009643_abnormal_urine_homeostasis | 0.76578524 |
142 | MP0002233_abnormal_nose_morphology | 0.76452015 |
143 | MP0009765_abnormal_xenobiotic_induced | 0.76154688 |
144 | MP0005384_cellular_phenotype | 0.75669840 |
145 | MP0002210_abnormal_sex_determination | 0.75188951 |
146 | MP0003119_abnormal_digestive_system | 0.74764525 |
147 | MP0004185_abnormal_adipocyte_glucose | 0.73491727 |
148 | MP0005257_abnormal_intraocular_pressure | 0.72693338 |
149 | MP0003656_abnormal_erythrocyte_physiolo | 0.72347098 |
150 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.70971445 |
151 | MP0008873_increased_physiological_sensi | 0.70635085 |
152 | MP0003566_abnormal_cell_adhesion | 0.70554801 |
153 | MP0009278_abnormal_bone_marrow | 0.70510584 |
154 | MP0001661_extended_life_span | 0.70505342 |
155 | MP0001542_abnormal_bone_strength | 0.69863417 |
156 | MP0001529_abnormal_vocalization | 0.69850386 |
157 | MP0003011_delayed_dark_adaptation | 0.69629781 |
158 | MP0000762_abnormal_tongue_morphology | 0.69059519 |
159 | MP0003693_abnormal_embryo_hatching | 0.68459126 |
160 | MP0002933_joint_inflammation | 0.67682527 |
161 | MP0008057_abnormal_DNA_replication | 0.67570988 |
162 | * MP0000689_abnormal_spleen_morphology | 0.67020922 |
163 | MP0001286_abnormal_eye_development | 0.67019528 |
164 | MP0001929_abnormal_gametogenesis | 0.64627306 |
165 | MP0003221_abnormal_cardiomyocyte_apopto | 0.64419619 |
166 | * MP0002019_abnormal_tumor_incidence | 0.64224174 |
167 | MP0001915_intracranial_hemorrhage | 0.63218929 |
168 | MP0003123_paternal_imprinting | 0.61680525 |
169 | MP0001145_abnormal_male_reproductive | 0.61515826 |
170 | MP0002092_abnormal_eye_morphology | 0.61424990 |
171 | MP0001216_abnormal_epidermal_layer | 0.60084187 |
172 | MP0004197_abnormal_fetal_growth/weight/ | 0.59797257 |
173 | MP0005365_abnormal_bile_salt | 0.57552186 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Eczematoid dermatitis (HP:0000976) | 6.40438443 |
2 | Recurrent gram-negative bacterial infections (HP:0005420) | 6.12024067 |
3 | Recurrent abscess formation (HP:0002722) | 5.89265652 |
4 | Recurrent bacterial skin infections (HP:0005406) | 5.55434283 |
5 | Abnormality of macrophages (HP:0004311) | 5.21066860 |
6 | Vacuolated lymphocytes (HP:0001922) | 4.22553789 |
7 | Multiple enchondromatosis (HP:0005701) | 4.19652817 |
8 | Mediastinal lymphadenopathy (HP:0100721) | 3.91200117 |
9 | Acute necrotizing encephalopathy (HP:0006965) | 3.83587529 |
10 | Stomatitis (HP:0010280) | 3.76084206 |
11 | Acute encephalopathy (HP:0006846) | 3.70769966 |
12 | Hepatosplenomegaly (HP:0001433) | 3.65153367 |
13 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.64036541 |
14 | Axonal loss (HP:0003447) | 3.56476392 |
15 | Microvesicular hepatic steatosis (HP:0001414) | 3.50317035 |
16 | Recurrent skin infections (HP:0001581) | 3.44219515 |
17 | Systemic lupus erythematosus (HP:0002725) | 3.41023650 |
18 | Parakeratosis (HP:0001036) | 3.40231644 |
19 | Autoimmune thrombocytopenia (HP:0001973) | 3.34184740 |
20 | Prolonged neonatal jaundice (HP:0006579) | 3.33467672 |
21 | Gingivitis (HP:0000230) | 3.31814595 |
22 | Increased CSF lactate (HP:0002490) | 3.30789147 |
23 | Poor head control (HP:0002421) | 3.29069513 |
24 | Chronic obstructive pulmonary disease (HP:0006510) | 3.24937986 |
25 | Obstructive lung disease (HP:0006536) | 3.24937986 |
26 | Nausea (HP:0002018) | 3.13888839 |
27 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.13760204 |
28 | Increased IgM level (HP:0003496) | 3.12133050 |
29 | Abnormality of methionine metabolism (HP:0010901) | 3.10540977 |
30 | Mitochondrial inheritance (HP:0001427) | 3.09484637 |
31 | Cerebral edema (HP:0002181) | 3.07433488 |
32 | Reticulocytopenia (HP:0001896) | 3.01780788 |
33 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 3.00644096 |
34 | Basal ganglia calcification (HP:0002135) | 3.00039160 |
35 | Increased cerebral lipofuscin (HP:0011813) | 2.97195749 |
36 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.96425850 |
37 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.89940758 |
38 | Progressive macrocephaly (HP:0004481) | 2.87700118 |
39 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.83705634 |
40 | Rough bone trabeculation (HP:0100670) | 2.82330977 |
41 | Tetraparesis (HP:0002273) | 2.79178963 |
42 | Reduced antithrombin III activity (HP:0001976) | 2.77830764 |
43 | Hepatocellular necrosis (HP:0001404) | 2.77790776 |
44 | Increased serum lactate (HP:0002151) | 2.73583238 |
45 | Recurrent pneumonia (HP:0006532) | 2.70638178 |
46 | Urticaria (HP:0001025) | 2.68793710 |
47 | Sparse eyelashes (HP:0000653) | 2.68147141 |
48 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.65008259 |
49 | Macrocytic anemia (HP:0001972) | 2.64459408 |
50 | Type I transferrin isoform profile (HP:0003642) | 2.64009322 |
51 | Prostate neoplasm (HP:0100787) | 2.62309063 |
52 | Chromsome breakage (HP:0040012) | 2.61069029 |
53 | Birth length less than 3rd percentile (HP:0003561) | 2.59887640 |
54 | Agnosia (HP:0010524) | 2.59822734 |
55 | Myocardial infarction (HP:0001658) | 2.57128796 |
56 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.55366039 |
57 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.55366039 |
58 | Abnormal hemoglobin (HP:0011902) | 2.54598307 |
59 | Lactic acidosis (HP:0003128) | 2.54296531 |
60 | Progressive muscle weakness (HP:0003323) | 2.53704641 |
61 | Degeneration of anterior horn cells (HP:0002398) | 2.52660544 |
62 | Abnormality of the anterior horn cell (HP:0006802) | 2.52660544 |
63 | Meckel diverticulum (HP:0002245) | 2.48978515 |
64 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.45013573 |
65 | Hepatic necrosis (HP:0002605) | 2.43320443 |
66 | Recurrent fungal infections (HP:0002841) | 2.42949419 |
67 | Spastic diplegia (HP:0001264) | 2.41052098 |
68 | Abnormality of serum amino acid levels (HP:0003112) | 2.40958692 |
69 | Increased serum pyruvate (HP:0003542) | 2.40061890 |
70 | Abnormality of glycolysis (HP:0004366) | 2.40061890 |
71 | Abnormality of the preputium (HP:0100587) | 2.39977426 |
72 | Abnormality of the umbilical cord (HP:0010881) | 2.39095928 |
73 | Exercise intolerance (HP:0003546) | 2.38644294 |
74 | Oral leukoplakia (HP:0002745) | 2.36930738 |
75 | Respiratory difficulties (HP:0002880) | 2.36238197 |
76 | Vasculitis (HP:0002633) | 2.35987452 |
77 | Interstitial pulmonary disease (HP:0006530) | 2.35833089 |
78 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.34269956 |
79 | Abnormalities of placenta or umbilical cord (HP:0001194) | 2.33771192 |
80 | Stenosis of the external auditory canal (HP:0000402) | 2.33114897 |
81 | Abnormal trabecular bone morphology (HP:0100671) | 2.29085730 |
82 | Selective tooth agenesis (HP:0001592) | 2.28702562 |
83 | Abnormality of the ileum (HP:0001549) | 2.28575178 |
84 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.28359546 |
85 | Abnormal umbilical cord blood vessels (HP:0011403) | 2.27220833 |
86 | Single umbilical artery (HP:0001195) | 2.27220833 |
87 | Abnormality of the fetal cardiovascular system (HP:0010948) | 2.27220833 |
88 | Facial cleft (HP:0002006) | 2.26733106 |
89 | Abnormal lung lobation (HP:0002101) | 2.26623377 |
90 | Respiratory failure (HP:0002878) | 2.26133460 |
91 | Thick nail (HP:0001805) | 2.25881845 |
92 | Increased intramyocellular lipid droplets (HP:0012240) | 2.25850569 |
93 | Leukodystrophy (HP:0002415) | 2.25053607 |
94 | Aplastic anemia (HP:0001915) | 2.22195343 |
95 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.21961625 |
96 | Megaloblastic anemia (HP:0001889) | 2.20753268 |
97 | Abnormal number of erythroid precursors (HP:0012131) | 2.20408450 |
98 | Exertional dyspnea (HP:0002875) | 2.20325002 |
99 | Increased serum ferritin (HP:0003281) | 2.18709331 |
100 | Steatorrhea (HP:0002570) | 2.16466600 |
101 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.15479799 |
102 | Ependymoma (HP:0002888) | 2.15160948 |
103 | Secondary amenorrhea (HP:0000869) | 2.14511988 |
104 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.14362831 |
105 | Fused cervical vertebrae (HP:0002949) | 2.13720346 |
106 | Glomerulonephritis (HP:0000099) | 2.12588723 |
107 | Trismus (HP:0000211) | 2.11869076 |
108 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.10793149 |
109 | Abnormality of alanine metabolism (HP:0010916) | 2.10793149 |
110 | Hyperalaninemia (HP:0003348) | 2.10793149 |
111 | Disinhibition (HP:0000734) | 2.09660579 |
112 | Lethargy (HP:0001254) | 2.08825151 |
113 | Recurrent lower respiratory tract infections (HP:0002783) | 2.08521519 |
114 | Abnormality of placental membranes (HP:0011409) | 2.08476169 |
115 | Amniotic constriction ring (HP:0009775) | 2.08476169 |
116 | Hypobetalipoproteinemia (HP:0003563) | 2.06668229 |
117 | Pathologic fracture (HP:0002756) | 2.06559010 |
118 | Autoimmune hemolytic anemia (HP:0001890) | 2.05751650 |
119 | Osteomyelitis (HP:0002754) | 2.05356503 |
120 | Abnormality of chromosome stability (HP:0003220) | 2.05087003 |
121 | Hydroxyprolinuria (HP:0003080) | 2.04981466 |
122 | Abnormality of proline metabolism (HP:0010907) | 2.04981466 |
123 | Cerebral hypomyelination (HP:0006808) | 2.04734471 |
124 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.04054182 |
125 | Colon cancer (HP:0003003) | 2.03185130 |
126 | Purpura (HP:0000979) | 2.02448735 |
127 | Cleft eyelid (HP:0000625) | 2.01767345 |
128 | Vertebral compression fractures (HP:0002953) | 2.01154826 |
129 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.00794986 |
130 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.00794986 |
131 | Abnormal protein glycosylation (HP:0012346) | 2.00794986 |
132 | Abnormal glycosylation (HP:0012345) | 2.00794986 |
133 | Joint hemorrhage (HP:0005261) | 1.99610841 |
134 | Posterior subcapsular cataract (HP:0007787) | 1.98274691 |
135 | Gout (HP:0001997) | 1.97738619 |
136 | Increased hepatocellular lipid droplets (HP:0006565) | 1.97301477 |
137 | Cellulitis (HP:0100658) | 1.96556754 |
138 | Pustule (HP:0200039) | 1.96133736 |
139 | Renal Fanconi syndrome (HP:0001994) | 1.96058823 |
140 | Horseshoe kidney (HP:0000085) | 1.95879108 |
141 | Intrahepatic cholestasis (HP:0001406) | 1.95469556 |
142 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.93698155 |
143 | Abnormality of iron homeostasis (HP:0011031) | 1.92462841 |
144 | Premature loss of primary teeth (HP:0006323) | 1.92403919 |
145 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.90420187 |
146 | Osteolytic defects of the hand bones (HP:0009699) | 1.90420187 |
147 | CNS demyelination (HP:0007305) | 1.90357239 |
148 | Postnatal microcephaly (HP:0005484) | 1.90147284 |
149 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.89645276 |
150 | Neoplasm of the adrenal gland (HP:0100631) | 1.87998452 |
151 | Abnormality of glycolipid metabolism (HP:0010969) | 1.87860729 |
152 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.87860729 |
153 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.87860729 |
154 | Esophageal varix (HP:0002040) | 1.87840401 |
155 | Progressive external ophthalmoplegia (HP:0000590) | 1.87366412 |
156 | Hypergammaglobulinemia (HP:0010702) | 1.86349210 |
157 | Dysphonia (HP:0001618) | 1.85511553 |
158 | Lipid accumulation in hepatocytes (HP:0006561) | 1.85363265 |
159 | Hypokinesia (HP:0002375) | 1.84811728 |
160 | Recurrent viral infections (HP:0004429) | 1.84212010 |
161 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.83895964 |
162 | Fat malabsorption (HP:0002630) | 1.83813971 |
163 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.83575825 |
164 | Cortical dysplasia (HP:0002539) | 1.82838177 |
165 | Bone pain (HP:0002653) | 1.82188303 |
166 | Pancytopenia (HP:0001876) | 1.81497863 |
167 | Absent radius (HP:0003974) | 1.81442267 |
168 | Hyperglycinemia (HP:0002154) | 1.81314249 |
169 | Leukocytosis (HP:0001974) | 1.80946991 |
170 | Increased muscle lipid content (HP:0009058) | 1.79979057 |
171 | Xanthomatosis (HP:0000991) | 1.79754391 |
172 | Death in infancy (HP:0001522) | 1.78983374 |
173 | Hyperglycinuria (HP:0003108) | 1.78402654 |
174 | Small intestinal stenosis (HP:0012848) | 1.76776141 |
175 | Duodenal stenosis (HP:0100867) | 1.76776141 |
176 | Orchitis (HP:0100796) | 1.76452039 |
177 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.76170877 |
178 | Abnormal gallbladder physiology (HP:0012438) | 1.75955043 |
179 | Porencephaly (HP:0002132) | 1.72300075 |
180 | Gingival bleeding (HP:0000225) | 1.72248765 |
181 | Conjunctival telangiectasia (HP:0000524) | 1.71513216 |
182 | Abnormality of T cell number (HP:0011839) | 1.70792087 |
183 | Erythroderma (HP:0001019) | 1.70095109 |
184 | Neurofibrillary tangles (HP:0002185) | 1.69680302 |
185 | Anorexia (HP:0002039) | 1.69571184 |
186 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.68359993 |
187 | Optic neuritis (HP:0100653) | 1.68307879 |
188 | Retrobulbar optic neuritis (HP:0100654) | 1.68307879 |
189 | Hypercholesterolemia (HP:0003124) | 1.68278089 |
190 | Prolonged partial thromboplastin time (HP:0003645) | 1.65797500 |
191 | Epidermoid cyst (HP:0200040) | 1.63921272 |
192 | Loss of speech (HP:0002371) | 1.63608836 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MST4 | 3.83072221 |
2 | MAP3K14 | 3.58457671 |
3 | TSSK6 | 3.54012302 |
4 | VRK2 | 3.51077601 |
5 | NEK1 | 3.40873784 |
6 | BLK | 3.34063271 |
7 | SRPK1 | 3.17625711 |
8 | TBK1 | 3.03923019 |
9 | NME2 | 2.92044330 |
10 | IRAK3 | 2.82422019 |
11 | RIPK4 | 2.78202027 |
12 | CDC7 | 2.73726630 |
13 | PDK2 | 2.65862560 |
14 | IRAK4 | 2.50991952 |
15 | STK16 | 2.36236152 |
16 | PIM2 | 2.35497452 |
17 | ABL2 | 2.33011788 |
18 | NME1 | 2.30385623 |
19 | MST1R | 2.19042534 |
20 | EIF2AK1 | 2.18525933 |
21 | TYK2 | 2.17704911 |
22 | STK39 | 2.07970063 |
23 | IKBKB | 2.06103327 |
24 | PLK3 | 2.04529600 |
25 | BUB1 | 1.92352730 |
26 | NEK9 | 1.85230716 |
27 | PAK4 | 1.84068180 |
28 | IKBKE | 1.81249448 |
29 | ERBB4 | 1.80448921 |
30 | TRIM28 | 1.77746886 |
31 | BCR | 1.72279470 |
32 | MET | 1.71147480 |
33 | MAP3K12 | 1.70511127 |
34 | TESK2 | 1.62151715 |
35 | PLK1 | 1.49125020 |
36 | RPS6KA4 | 1.48861808 |
37 | EPHB1 | 1.48017430 |
38 | TAF1 | 1.44302547 |
39 | SCYL2 | 1.38575904 |
40 | TESK1 | 1.37547999 |
41 | BRSK2 | 1.35180288 |
42 | JAK3 | 1.34861777 |
43 | BMPR2 | 1.26492280 |
44 | SMG1 | 1.24446304 |
45 | EIF2AK3 | 1.22908204 |
46 | BRSK1 | 1.16137016 |
47 | MKNK2 | 1.15445330 |
48 | LIMK1 | 1.14858881 |
49 | AURKB | 1.12639985 |
50 | EIF2AK2 | 1.10845608 |
51 | CHEK2 | 1.09015513 |
52 | * PBK | 1.08531239 |
53 | ACVR1B | 1.08265633 |
54 | TXK | 1.06011308 |
55 | TRPM7 | 1.03628701 |
56 | BMX | 1.02844115 |
57 | MARK3 | 1.02602917 |
58 | LATS2 | 1.02529913 |
59 | PLK4 | 1.02383396 |
60 | PIM1 | 1.00408710 |
61 | CHUK | 0.98763243 |
62 | ARAF | 0.97910470 |
63 | LYN | 0.97029969 |
64 | FGR | 0.96496741 |
65 | CSK | 0.95951524 |
66 | STK10 | 0.95062903 |
67 | ALK | 0.94607115 |
68 | MAP3K13 | 0.92516170 |
69 | IRAK1 | 0.92035617 |
70 | KIT | 0.91491518 |
71 | OXSR1 | 0.91003702 |
72 | RPS6KB2 | 0.87963180 |
73 | TLK1 | 0.86186487 |
74 | JAK1 | 0.85421558 |
75 | CDK7 | 0.85238478 |
76 | EPHA2 | 0.85130777 |
77 | BMPR1B | 0.85065135 |
78 | ATR | 0.84502952 |
79 | YES1 | 0.83944796 |
80 | TNIK | 0.82716125 |
81 | WEE1 | 0.79429582 |
82 | WNK4 | 0.78967724 |
83 | AURKA | 0.78861079 |
84 | MAP3K11 | 0.74816329 |
85 | CLK1 | 0.73733160 |
86 | RPS6KA5 | 0.73579678 |
87 | CHEK1 | 0.73084335 |
88 | ERBB3 | 0.72901272 |
89 | IRAK2 | 0.72817798 |
90 | LMTK2 | 0.70402432 |
91 | ZAK | 0.69366227 |
92 | ABL1 | 0.69305532 |
93 | DAPK1 | 0.67133941 |
94 | PRKCD | 0.65403105 |
95 | NEK2 | 0.64344308 |
96 | ILK | 0.63427317 |
97 | MKNK1 | 0.62885841 |
98 | MATK | 0.62774989 |
99 | MAP3K3 | 0.62643307 |
100 | GRK7 | 0.61696927 |
101 | CDK6 | 0.61146740 |
102 | CSNK2A2 | 0.60252466 |
103 | KDR | 0.59871614 |
104 | MAP3K5 | 0.59723449 |
105 | STK3 | 0.58871283 |
106 | PNCK | 0.58232912 |
107 | MAP3K8 | 0.58173160 |
108 | EGFR | 0.56579883 |
109 | ADRBK2 | 0.55732255 |
110 | FGFR1 | 0.55408223 |
111 | * LCK | 0.54704734 |
112 | MOS | 0.53547407 |
113 | DYRK2 | 0.53185733 |
114 | EPHA3 | 0.52676016 |
115 | VRK1 | 0.52341307 |
116 | DAPK3 | 0.51455949 |
117 | NLK | 0.48939468 |
118 | NEK6 | 0.48326266 |
119 | AKT2 | 0.48215287 |
120 | ATM | 0.48196985 |
121 | NUAK1 | 0.48073633 |
122 | PRKCQ | 0.48028512 |
123 | BCKDK | 0.47993850 |
124 | BRAF | 0.47792447 |
125 | PRKCI | 0.46977198 |
126 | PKN1 | 0.46773500 |
127 | JAK2 | 0.46098302 |
128 | LRRK2 | 0.46052871 |
129 | CDK8 | 0.45866689 |
130 | MAPKAPK5 | 0.45856412 |
131 | TTK | 0.45128394 |
132 | HCK | 0.43101193 |
133 | FGFR4 | 0.42625506 |
134 | CSNK2A1 | 0.41861032 |
135 | DYRK3 | 0.41613413 |
136 | CSNK1E | 0.41150800 |
137 | PASK | 0.41111688 |
138 | CSNK1G1 | 0.40779837 |
139 | SYK | 0.39968787 |
140 | ERN1 | 0.39740565 |
141 | MAP4K1 | 0.39485827 |
142 | CCNB1 | 0.38490086 |
143 | PAK1 | 0.37762641 |
144 | CSNK1G3 | 0.37640279 |
145 | MYLK | 0.37582664 |
146 | ZAP70 | 0.36756965 |
147 | MELK | 0.36664173 |
148 | PRKG2 | 0.36421917 |
149 | * CDK1 | 0.35182321 |
150 | MAP2K2 | 0.34579972 |
151 | TAOK2 | 0.34040944 |
152 | STK38L | 0.32613287 |
153 | CDK2 | 0.31125926 |
154 | CDK9 | 0.29749083 |
155 | CDK4 | 0.29364439 |
156 | PAK2 | 0.24308366 |
157 | CAMK2G | 0.23820836 |
158 | CSNK1A1L | 0.23712925 |
159 | LATS1 | 0.23504605 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Proteasome_Homo sapiens_hsa03050 | 3.36548897 |
2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.91869320 |
3 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.91157967 |
4 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.72608650 |
5 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.57230095 |
6 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.53419483 |
7 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.37213319 |
8 | Spliceosome_Homo sapiens_hsa03040 | 2.18385342 |
9 | Allograft rejection_Homo sapiens_hsa05330 | 2.16531635 |
10 | Legionellosis_Homo sapiens_hsa05134 | 2.13113077 |
11 | Leishmaniasis_Homo sapiens_hsa05140 | 2.11350350 |
12 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.07028195 |
13 | Non-homologous end-joining_Homo sapiens_hsa03450 | 2.04326030 |
14 | RNA transport_Homo sapiens_hsa03013 | 2.01668349 |
15 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.96700246 |
16 | Base excision repair_Homo sapiens_hsa03410 | 1.95236994 |
17 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.92653430 |
18 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.82000313 |
19 | Malaria_Homo sapiens_hsa05144 | 1.81322200 |
20 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.75851601 |
21 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.75072307 |
22 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.71150285 |
23 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.69073227 |
24 | Pertussis_Homo sapiens_hsa05133 | 1.68126342 |
25 | Carbon metabolism_Homo sapiens_hsa01200 | 1.67191621 |
26 | Phagosome_Homo sapiens_hsa04145 | 1.65416545 |
27 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.61761207 |
28 | Asthma_Homo sapiens_hsa05310 | 1.61623294 |
29 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.60528346 |
30 | Cell cycle_Homo sapiens_hsa04110 | 1.55857801 |
31 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.50722551 |
32 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.44753499 |
33 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.43807372 |
34 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.43387945 |
35 | Lysosome_Homo sapiens_hsa04142 | 1.42690518 |
36 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.42669734 |
37 | Protein export_Homo sapiens_hsa03060 | 1.38119181 |
38 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.37477579 |
39 | Tuberculosis_Homo sapiens_hsa05152 | 1.36379609 |
40 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.33632705 |
41 | Basal transcription factors_Homo sapiens_hsa03022 | 1.29682775 |
42 | Histidine metabolism_Homo sapiens_hsa00340 | 1.28086508 |
43 | Salmonella infection_Homo sapiens_hsa05132 | 1.26657657 |
44 | Measles_Homo sapiens_hsa05162 | 1.20694625 |
45 | RNA degradation_Homo sapiens_hsa03018 | 1.19829330 |
46 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.19359504 |
47 | Ribosome_Homo sapiens_hsa03010 | 1.16836188 |
48 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.16644551 |
49 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.15649318 |
50 | RNA polymerase_Homo sapiens_hsa03020 | 1.13461938 |
51 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.13342155 |
52 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.11625927 |
53 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.11478658 |
54 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.11408194 |
55 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.10633993 |
56 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.10163617 |
57 | Influenza A_Homo sapiens_hsa05164 | 1.10111228 |
58 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.10005721 |
59 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.07722337 |
60 | Purine metabolism_Homo sapiens_hsa00230 | 1.07577480 |
61 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.07502082 |
62 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.07258238 |
63 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.06839004 |
64 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.05801708 |
65 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.03977711 |
66 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.03336233 |
67 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.02099180 |
68 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.01152737 |
69 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.00563454 |
70 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.98496421 |
71 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.98368844 |
72 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.97439189 |
73 | Mineral absorption_Homo sapiens_hsa04978 | 0.93159966 |
74 | Parkinsons disease_Homo sapiens_hsa05012 | 0.93000247 |
75 | Galactose metabolism_Homo sapiens_hsa00052 | 0.92805280 |
76 | Mismatch repair_Homo sapiens_hsa03430 | 0.91927757 |
77 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.91149257 |
78 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.88512711 |
79 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.88437527 |
80 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.86954612 |
81 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.86836408 |
82 | Sulfur relay system_Homo sapiens_hsa04122 | 0.84499240 |
83 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.83778857 |
84 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.82610286 |
85 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.81624823 |
86 | DNA replication_Homo sapiens_hsa03030 | 0.81082340 |
87 | Homologous recombination_Homo sapiens_hsa03440 | 0.80907125 |
88 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.79001490 |
89 | Apoptosis_Homo sapiens_hsa04210 | 0.76739545 |
90 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.75382173 |
91 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.75216245 |
92 | Metabolic pathways_Homo sapiens_hsa01100 | 0.75005241 |
93 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.74746984 |
94 | * Peroxisome_Homo sapiens_hsa04146 | 0.74119444 |
95 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.74021132 |
96 | Shigellosis_Homo sapiens_hsa05131 | 0.72694405 |
97 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.72328391 |
98 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.71941154 |
99 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.71923554 |
100 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.69049852 |
101 | Retinol metabolism_Homo sapiens_hsa00830 | 0.67049501 |
102 | Prion diseases_Homo sapiens_hsa05020 | 0.64482769 |
103 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.64288902 |
104 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.62918364 |
105 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.62584827 |
106 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.61365263 |
107 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.61190917 |
108 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.60941050 |
109 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.60754358 |
110 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.60638678 |
111 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.60391837 |
112 | Huntingtons disease_Homo sapiens_hsa05016 | 0.60088997 |
113 | Other glycan degradation_Homo sapiens_hsa00511 | 0.58690125 |
114 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.56927555 |
115 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.56259299 |
116 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.55655820 |
117 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.55601417 |
118 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.55305730 |
119 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.54952711 |
120 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.54495260 |
121 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.54414677 |
122 | Hepatitis C_Homo sapiens_hsa05160 | 0.53437338 |
123 | Alzheimers disease_Homo sapiens_hsa05010 | 0.52671385 |
124 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.52025870 |
125 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.51222107 |
126 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.48607661 |
127 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.48319408 |
128 | Viral myocarditis_Homo sapiens_hsa05416 | 0.48260025 |
129 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.48052239 |
130 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.47180586 |
131 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.45749167 |
132 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.45611196 |
133 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.44429579 |
134 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.44235721 |
135 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.42780106 |
136 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.42679653 |
137 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.42602731 |
138 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.41786880 |
139 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.36632054 |
140 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.33103532 |
141 | Thyroid cancer_Homo sapiens_hsa05216 | 0.32100396 |
142 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.30978071 |
143 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.28372574 |
144 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.23739093 |
145 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.22930864 |
146 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.21637592 |
147 | Tight junction_Homo sapiens_hsa04530 | 0.20541770 |
148 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.20243919 |
149 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.20199367 |